ADIL
NASDAQ · Pharmaceuticals
Adial Pharmaceuticals Inc
$1.43
+0.01 (+0.70%)
Open$1.45
Previous Close$1.42
Day High$1.49
Day Low$1.40
52W High$440.66
52W Low—
Volume—
Avg Volume96.9K
Market Cap2.04M
P/E Ratio—
EPS$-16.98
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,128.7% upside
Current
$1.43
$1.43
Target
$17.57
$17.57
$13.09
$17.57 avg
$22.70
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 13.49M | 12.56M | 11.54M |
| Net Income | 2.10M | 2.52M | 1.69M |
| Profit Margin | 15.6% | 20.1% | 14.6% |
| EBITDA | 3.80M | 3.63M | 3.04M |
| Free Cash Flow | 1.15M | 1.06M | 1.39M |
| Rev Growth | +2.7% | +18.2% | +12.4% |
| Debt/Equity | 0.15 | 0.14 | 0.18 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |